Pulmonary Complications in a Child with Kawasaki Disease Shock Syndrome: A Case Study
-
By
-
Xuhua Xia
-
Jiwei Zhou
-
Lan Chen
-
Lei Zhang
-
September 7, 2026
Clinical Scorecard: Pulmonary Complications in a Child with Kawasaki Disease Shock Syndrome: A Case Study
At a Glance
| Category | Detail |
|---|
| Condition | Kawasaki Disease Shock Syndrome (KDSS) |
| Key Mechanisms | Acute systemic vasculitis with potential pulmonary involvement and increased vascular permeability. |
| Target Population | Children, particularly those under 5 years of age. |
| Care Setting | Pediatric intensive care unit (ICU). |
Key Highlights
- KDSS is a severe complication of Kawasaki disease characterized by significant inflammatory abnormalities.
- Pulmonary involvement in KD is rare but can lead to severe respiratory distress.
- The case describes a 9-year-old boy who developed acute dyspnea during IVIG treatment for KDSS.
- Mechanical ventilation was required, but the patient achieved complete recovery.
- Follow-up showed no coronary dilatation or pulmonary fibrosis.
Guideline-Based Recommendations
Diagnosis
- Diagnosis of Kawasaki disease should follow the American Heart Association criteria.
Management
- Intravenous immunoglobulin (IVIG) and aspirin are standard treatments for Kawasaki disease.
Monitoring & Follow-up
- Monitor for respiratory distress and pulmonary complications during treatment.
Risks
- KDSS increases the risk of coronary artery abnormalities and myocardial dysfunction.
Patient & Prescribing Data
Children diagnosed with Kawasaki disease, particularly those presenting with severe symptoms.
Early aggressive management with IVIG and monitoring for pulmonary complications is crucial.
Clinical Best Practices
- Administer IVIG promptly in cases of Kawasaki disease.
- Monitor respiratory status closely in patients with KDSS.
- Consider mechanical ventilation for severe respiratory distress.
Related Resources & Content
